# Vivus, LLC. – FDA Inspection, Sep 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/vivus-llc/26cb5c82-6f36-457e-9b98-5f9d226b776f
Source feed: FDA_Inspections

> FDA inspection 1338264 of Vivus, LLC., September 28, 2026. 1 citation under 21 CFR part 314. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1338264
- Company Name: Vivus, LLC.
- Inspection Date: 2026-09-28
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1218963 - 2023-09-08
- FDA Inspection 1081231 - 2018-11-28
- FDA Inspection 865709 - 2014-01-31
- [FDA Inspection 829906 - 2013-04-26](https://www.keypedia.com/records/fda_inspections/vivus-llc/b00ba888-0fb9-425f-8712-2fa7f2ccb340)
- FDA Inspection 756318 - 2011-11-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/vivus-llc/d76510d4-f605-4c76-ac22-3bf3cc6afd33

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df